Patent · US Active

KV1.3 inhibitors and their medical application

US10822345B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

4SC AG · DE

Inventors

Stefan Tasler · Hanerau-Hademarschen, DE
Ilga KRIMMELBEIN · Munich, DE
Juergen Kraus · Andechs, DE
Mirko Zaja · Birkenfeld, DE

Key dates

Filing date	Mar 14, 2016
Grant date	Nov 3, 2020
Priority date	—
Expiry date	Mar 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (II) or a pharmaceutically acceptable salt or solvate thereof, the medical uses thereof for diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial, and methods for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.